← Back to Clinical Trials
Recruiting NCT05565885

NCT05565885 Search for BIO Diagnostic and Prognostic Markers in Adult VAScularitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05565885
Status Recruiting
Phase
Sponsor University Hospital, Tours
Condition Vasculitis
Study Type OBSERVATIONAL
Enrollment 225 participants
Start Date 2022-11-22
Primary Completion 2037-12

Eligibility & Interventions

Sex All sexes
Min Age 16 Years
Max Age N/A
Study Type OBSERVATIONAL
Interventions
Sampling

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

What to Expect as a Participant

This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.

This trial targets 225 participants in total. It began in 2022-11-22 with a primary completion date of 2037-12.

⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.

Brief Summary

To date, there are no reliable diagnostic blood markers of adult vasculitis. To date, the diagnosis of vasculitis is based on invasive procedure, biopsy of affected tissues potentially at risk of complication . In addition, there are no reliable biomarkers to predict the evolution of vasculitis (relapse, refractory form ...) necessary for the management of patients (type of treatment, duration ..) Prospective study, monocentric (CHU de Tours), non-interventional, aimed at finding diagnostic and prognostic biomarkers (both metabolomic and immunologic) in adult vasculitis patients.

Eligibility Criteria

Inclusion Criteria: * Age \> 16 years * Active vasculitis, new diagnosis or relapse * IgA vasculitis * ANCA vasculitis * Giant cell arteritis Exclusion Criteria: * Person who has objected to the processing of data * Pregnant woman * Patient positive for HIV, HBV, HCV * Treatment in the previous month with corticosteroids, immunosuppressive drugs or biotherapy. * Patient unable to understand the information leaflet * Adult under guardianship or curatorship

Contact & Investigator

Central Contact

Alexandra Audemard verger

✉ alexandra.audemardverger@univ-tours.fr

📞 02 47 47 37 15

Frequently Asked Questions

Who can join the NCT05565885 clinical trial?

This trial is open to participants of all sexes, aged 16 Years or older, studying Vasculitis. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.

Is NCT05565885 currently recruiting?

Yes, NCT05565885 is actively recruiting participants. Contact the research team at alexandra.audemardverger@univ-tours.fr for enrollment information.

Where is the NCT05565885 trial being conducted?

This trial is being conducted at Tours, France.

Who is sponsoring the NCT05565885 clinical trial?

NCT05565885 is sponsored by University Hospital, Tours. The trial plans to enroll 225 participants.

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: July 2026  ·  Data Methodology